Cargando…

Enzymatic Properties of the Neuraminidase of Seasonal H1N1 Influenza Viruses Provide Insights for the Emergence of Natural Resistance to Oseltamivir

Detalles Bibliográficos
Autores principales:	Rameix-Welti, Marie-Anne, Enouf, Vincent, Cuvelier, Frédérique, Jeannin, Patricia, van der Werf, Sylvie
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2008
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453323/ https://www.ncbi.nlm.nih.gov/pubmed/18654625 http://dx.doi.org/10.1371/journal.ppat.1000103

Ejemplares similares

I223R Mutation in Influenza A(H1N1)pdm09 Neuraminidase Confers Reduced Susceptibility to Oseltamivir and Zanamivir and Enhanced Resistance with H275Y
por: LeGoff, Jérome, et al.
Publicado: (2012)

Enhancement of the Influenza A Hemagglutinin (HA)-Mediated Cell-Cell Fusion and Virus Entry by the Viral Neuraminidase (NA)
por: Su, Bin, et al.
Publicado: (2009)

Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial
por: Duval, Xavier, et al.
Publicado: (2010)

Correction: Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial
por: Duval, Xavier, et al.
Publicado: (2010)

Oseltamivir-Resistant Influenza Virus A (H1N1), Europe, 2007–08 Season
por: Meijer, Adam, et al.
Publicado: (2009)

In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2015)

Binding mechanism of oseltamivir and influenza neuraminidase suggests perspectives for the design of new anti-influenza drugs
por: Tao, Jiaye, et al.
Publicado: (2022)

Synthesis and Biological Evaluation of NH(2)-Sulfonyl Oseltamivir Analogues as Influenza Neuraminidase Inhibitors
por: Hu, Yaping, et al.
Publicado: (2019)

Epistatic interactions between neuraminidase mutations facilitated the emergence of the oseltamivir-resistant H1N1 influenza viruses
por: Duan, Susu, et al.
Publicado: (2014)

Discovery of oseltamivir-based novel PROTACs as degraders targeting neuraminidase to combat H1N1 influenza virus
por: Xu, Zhichao, et al.
Publicado: (2022)

Anti-Influenza Neuraminidase Inhibitor Oseltamivir Phosphate Induces Canine Mammary Cancer Cell Aggressiveness
por: de Oliveira, Joana T., et al.
Publicado: (2015)

Structure-based design of 5′-substituted 1,2,3-triazolylated oseltamivir derivatives as potent influenza neuraminidase inhibitors
por: Wang, Pengfei, et al.
Publicado: (2021)

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
por: Hurt, Aeron C., et al.
Publicado: (2016)

A Computational-Experimental Approach Identifies Mutations That Enhance Surface Expression of an Oseltamivir-Resistant Influenza Neuraminidase
por: Bloom, Jesse D., et al.
Publicado: (2011)

Seasonal Genetic Drift of Human Influenza A Virus Quasispecies Revealed by Deep Sequencing
por: Barbezange, Cyril, et al.
Publicado: (2018)

Oseltamivir-Resistant Influenza Viruses A (H1N1) during 2007–2009 Influenza Seasons, Japan
por: Ujike, Makoto, et al.
Publicado: (2010)

Estimating the Fitness Advantage Conferred by Permissive Neuraminidase Mutations in Recent Oseltamivir-Resistant A(H1N1)pdm09 Influenza Viruses
por: Butler, Jeff, et al.
Publicado: (2014)

Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses
por: Singh, Ashona, et al.
Publicado: (2015)

The Emergence of Oseltamivir-Resistant Seasonal Influenza A (H1N1) Virus in Korea During the 2008-2009 Season
por: Choi, Woo-Young, et al.
Publicado: (2011)

Bidirectional Human–Swine Transmission of Seasonal Influenza A(H1N1)pdm09 Virus in Pig Herd, France, 2018
por: Chastagner, Amélie, et al.
Publicado: (2019)

Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients
por: Dutkowski, Regina
Publicado: (2010)

A Novel I221L Substitution in Neuraminidase Confers High-Level Resistance to Oseltamivir in Influenza B Viruses
por: Escuret, Vanessa, et al.
Publicado: (2014)

Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineages
por: Janies, Daniel A, et al.
Publicado: (2010)

Productive Infection of Human Skeletal Muscle Cells by Pandemic and Seasonal Influenza A(H1N1) Viruses
por: Desdouits, Marion, et al.
Publicado: (2013)

Dry extract BNO 1011 inhibits human influenza a replication and neuraminidase activity in oseltamivir-resistant and -sensitive viral strains
por: Seifert, Stephanie, et al.
Publicado: (2013)

A novel N-heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation
por: Zhang, Jiwei, et al.
Publicado: (2023)

Comparisons of oseltamivir‐resistant (H275Y) and concurrent oseltamivir‐susceptible seasonal influenza A(H1N1) virus infections in hospitalized adults, 2008–2009
por: Chan, Martin C. W., et al.
Publicado: (2012)

Foreword: Oseltamivir for seasonal, avian and pandemic influenza: 10 years of clinical experience
por: Nguyen-Van-Tam, Jonathan S.
Publicado: (2010)

No Incongruity in Respiratory Syncytial Virus M2-1 Protein Remaining Bound to Viral mRNAs during Their Entire Life Time
por: Rameix-Welti, Marie-Anne
Publicado: (2019)

Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011)

Contribution of Neuraminidase to the Efficacy of Seasonal Split Influenza Vaccines in the Ferret Model
por: Rosu, Miruna E., et al.
Publicado: (2022)

Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase
por: Rudrawar, Santosh, et al.
Publicado: (2010)

I222 Neuraminidase Mutations Further Reduce Oseltamivir Susceptibility of Indonesian Clade 2.1 Highly Pathogenic Avian Influenza A(H5N1) Viruses
por: McKimm-Breschkin, Jennifer L., et al.
Publicado: (2013)

Deletions of neuraminidase and resistance to oseltamivir may be a consequence of restricted receptor specificity in recent H3N2 influenza viruses
por: Gulati, Shelly, et al.
Publicado: (2009)

Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020
por: Adlhoch, Cornelia, et al.
Publicado: (2023)

Structural analysis of the novel influenza A (H7N9) viral Neuraminidase interactions with current approved neuraminidase inhibitors Oseltamivir, Zanamivir, and Peramivir in the presence of mutation R289K
por: Tran-To Su, Chinh, et al.
Publicado: (2013)

Expression and Characterization of Recombinant, Tetrameric and Enzymatically Active Influenza Neuraminidase for the Setup of an Enzyme-Linked Lectin-Based Assay
por: Prevato, Marua, et al.
Publicado: (2015)

Safety and tolerability of a 6‐week course of oseltamivir prophylaxis for seasonal influenza in children
por: Reisinger, Keith, et al.
Publicado: (2012)

Oseltamivir Treatment for Influenza During the Flu Season of 2018–2019: A Longitudinal Study
por: Li, Xiao-Guang, et al.
Publicado: (2022)

Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness
por: Brookes, Daniel W., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_capjjcquhnhe9ve2qm89qfd02u